These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 27000936)

  • 1. Interleukin 33: an innate alarm for adaptive responses beyond Th2 immunity-emerging roles in obesity, intestinal inflammation, and cancer.
    Schwartz C; O'Grady K; Lavelle EC; Fallon PG
    Eur J Immunol; 2016 May; 46(5):1091-100. PubMed ID: 27000936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-33 Alarmin and Its Active Proinflammatory Fragments Are Released in Small Intestine in Celiac Disease.
    Perez F; Ruera CN; Miculan E; Carasi P; Dubois-Camacho K; Garbi L; Guzman L; Hermoso MA; Chirdo FG
    Front Immunol; 2020; 11():581445. PubMed ID: 33133101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-33 and the intestine: The good, the bad, and the inflammatory.
    Hodzic Z; Schill EM; Bolock AM; Good M
    Cytokine; 2017 Dec; 100():1-10. PubMed ID: 28687373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-33: biological properties, functions, and roles in airway disease.
    Drake LY; Kita H
    Immunol Rev; 2017 Jul; 278(1):173-184. PubMed ID: 28658560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-33 in Systemic Sclerosis: Expression and Pathogenesis.
    Li L; Zhu H; Zuo X
    Front Immunol; 2018; 9():2663. PubMed ID: 30498500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New dog and new tricks: evolving roles for IL-33 in type 2 immunity.
    Lott JM; Sumpter TL; Turnquist HR
    J Leukoc Biol; 2015 Jun; 97(6):1037-48. PubMed ID: 25801770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New perspectives on IL-33 and IL-1 family cytokines as innate environmental sensors.
    Scott IC; Rees DG; Cohen ES
    Biochem Soc Trans; 2018 Oct; 46(5):1345-1353. PubMed ID: 30301844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 immunity in tissue repair and fibrosis.
    Gieseck RL; Wilson MS; Wynn TA
    Nat Rev Immunol; 2018 Jan; 18(1):62-76. PubMed ID: 28853443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlling the burn and fueling the fire: defining the role for the alarmin interleukin-33 in alloimmunity.
    Liu Q; Turnquist HR
    Curr Opin Organ Transplant; 2016 Feb; 21(1):45-52. PubMed ID: 26709577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alarmins and immunity.
    Yang D; Han Z; Oppenheim JJ
    Immunol Rev; 2017 Nov; 280(1):41-56. PubMed ID: 29027222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelium: the interplay between innate and Th2 immunity.
    Bulek K; Swaidani S; Aronica M; Li X
    Immunol Cell Biol; 2010; 88(3):257-68. PubMed ID: 20065993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of group 2 innate lymphoid cells.
    Duerr CU; Fritz JH
    Cytokine; 2016 Nov; 87():1-8. PubMed ID: 27255596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-33, an Alarmin of the IL-1 Family Involved in Allergic and Non Allergic Inflammation: Focus on the Mechanisms of Regulation of Its Activity.
    Cayrol C
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory Arthritis and Bone Metabolism Regulated by Type 2 Innate and Adaptive Immunity.
    Omata Y; Frech M; Saito T; Schett G; Zaiss MM; Tanaka S
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-Restricted Adaptive Type 2 Immunity Is Orchestrated by Expression of the Costimulatory Molecule OX40L on Group 2 Innate Lymphoid Cells.
    Halim TYF; Rana BMJ; Walker JA; Kerscher B; Knolle MD; Jolin HE; Serrao EM; Haim-Vilmovsky L; Teichmann SA; Rodewald HR; Botto M; Vyse TJ; Fallon PG; Li Z; Withers DR; McKenzie ANJ
    Immunity; 2018 Jun; 48(6):1195-1207.e6. PubMed ID: 29907525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Group 2 innate lymphoid cells in the regulation of immune responses.
    Roediger B; Weninger W
    Adv Immunol; 2015; 125():111-54. PubMed ID: 25591466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-33: increasing role in dermatological conditions.
    Balato A; Raimondo A; Balato N; Ayala F; Lembo S
    Arch Dermatol Res; 2016 Jul; 308(5):287-96. PubMed ID: 26969580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang Cytokine.
    Fournié JJ; Poupot M
    Front Immunol; 2018; 9():2506. PubMed ID: 30416507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of type 2 immunity in intestinal inflammation.
    Bamias G; Cominelli F
    Curr Opin Gastroenterol; 2015 Nov; 31(6):471-6. PubMed ID: 26376478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPAR-γ in innate and adaptive lung immunity.
    Nobs SP; Kopf M
    J Leukoc Biol; 2018 Oct; 104(4):737-741. PubMed ID: 29768688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.